MedTrace Logo

Major Liver Resection: Early Clotting Disorders and Functional Impairment.

NCT02813538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-21

No results posted yet for this study

Summary

The aim of this study is to evaluate early clotting disorders through thromboelastogram and anticoagulant proteins levels (maybe also endothelial markers) and liver function by indocyanine green clearance after major liver resection and search for a potential relationship between them.

Conditions

  • Hepatic Insufficiency
  • Blood Coagulation Disorders

Interventions

DRUG

Indocyanine green clearance

To evaluate liver function by injection of indocyanine green by a peripheral vein and measure its clearance

OTHER

Thromboelastometry

To evaluate blood coagulation impairment by obtaining blood sample from a peripheral vein and measure anticoagulant proteins levels plus obtaining thromboelastometry

Sponsors & Collaborators

  • Hospital General Universitario Gregorio Marañon

    lead OTHER

Principal Investigators

  • Luis Olmedilla, PhD · Gregorio Marañon Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-05
Primary Completion
2018-10-31
Completion
2019-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813538 on ClinicalTrials.gov